Back to Search Start Over

DCDC2 Mutations Cause Neonatal Sclerosing Cholangitis.

Authors :
Girard, Muriel
Bizet, Albane A.
Lachaux, Alain
Gonzales, Emmanuel
Filhol, Emilie
Collardeau‐Frachon, Sophie
Jeanpierre, Cécile
Henry, Charline
Fabre, Monique
Viremouneix, Loic
Galmiche, Louise
Debray, Dominique
Bole‐Feysot, Christine
Nitschke, Patrick
Pariente, Danièle
Guettier, Catherine
Lyonnet, Stanislas
Heidet, Laurence
Bertholet, Aurelia
Jacquemin, Emmanuel
Source :
Human Mutation; Oct2016, Vol. 37 Issue 10, p1025-1029, 5p
Publication Year :
2016

Abstract

ABSTRACT Neonatal sclerosing cholangitis (NSC) is a rare biliary disease leading to liver transplantation in childhood. Patients with NSC and ichtyosis have already been identified with a CLDN1 mutation, encoding a tight-junction protein. However, for the majority of patients, the molecular basis of NSC remains unknown. We identified biallelic missense mutations or in-frame deletion in DCDC2 in four affected children. Mutations involve highly conserved amino acids in the doublecortin domains of the protein. In cholangiocytes, DCDC2 protein is normally located in the cytoplasm and cilia, whereas in patients the mutated protein is accumulated in the cytoplasm, absent from cilia, and associated with ciliogenesis defect. This is the first report of DCDC2 mutations in NSC. This data expands the molecular spectrum of NSC, that can be considered as a ciliopathy and also expands the clinical spectrum of the DCDC2 mutations, previously reported in dyslexia, deafness, and nephronophtisis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10597794
Volume :
37
Issue :
10
Database :
Complementary Index
Journal :
Human Mutation
Publication Type :
Academic Journal
Accession number :
118056744
Full Text :
https://doi.org/10.1002/humu.23031